Long Focus Capital Management LLC 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 4:40 pm Purchase | 2024-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | Long Focus Capital Management LLC | 20,494,393 8.000% | 8,407,478 (+69.56%) | Filing |
| 2024-02-14 5:04 pm Purchase | 2023-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | Long Focus Capital Management LLC | 12,086,915 5.300% | 774,568 (+6.85%) | Filing |
| 2023-11-08 12:59 pm Purchase | 2023-10-31 | 13G | Adaptimmune Therapeutics plc ADAP | Long Focus Capital Management LLC | 11,312,347 5.000% | 11,312,347 (New Position) | Filing |